Dorsch Marion

Avg. Two Year Performance

No purchase track record

(3%) Avg. Sale Return

(1%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(4%)	(4%)	(9%)	4%	(3%)
Sale Success Rate	6 of 12	8 of 12	5 of 12	4 of 12	2 of 12

Blueprint Medicines Corp

Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 15.25K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--